Embolization of Blood Vessels as a Cancer Therapy Using Magnetorheological Fluids

Abstract

This paper demonstrates a possible in vitro cancer therapy by mechanically blocking the blood vessels to a tumor through injecting a model magnetorheological (MR) fluid and applying an external magnetic field. The biocompatible MR fluid is made of magnetite particles coated with starch and suspended in either water or sheep blood. Two particle sizes of 1.0 and 0.25 μm are used. A simple blood network consists of four branches of blood vessels made of silicone tubes of 0.4 mm in diameter. One of the branches contains a tumor made of a cylindrical cavity with a diameter of either 3.0 or 5.0 mm to simulate stage II or III tumors. The cavity is connected with either two or four vessels to the rest of the branch and is placed between two magnetic poles. By measuring the weight of the leaking fluid downstream from the magnets, the sealing quality is monitored. A dilute MR fluid (1.0% particle volume fraction) is pumped slowly through the network. As the fluid goes through the cavity, seals form within seconds after a magnetic field (0.43-0.62 T) is turned on. They block the fluid flow to the tumor. With sheep blood as the suspension medium, both size of magnetite particles form a good quality seal for the 3 mm cavity. Thus, a mechanical method for stopping blood flow is demonstrated in a multi-tube blood network for stage II tumor.

Keywords

magnetorheological fluids cancer therapy embolization biocompatibility magnetism

Get full access to this article

View all access options for this article.

References

“Angiogenesis Inhibitors in Cancer Research,” National Cancer Institute Cancer Trials Online, April 2, 1999. www.nci.nih.gov.

Berne, R.M. and Levy, M.N. 1986. Cardiovascular Physiology, 5th Edn. C. V. Mosby, Co., St. Louis.

Brownlee, S. November 8, 1999. “When will We Cure Cancer?,” Time Magazine, 80.

Brownlee, S. and Shute, N. May 18, 1998. “Killing Cancer,” U.S. News & World Report, 62.

Flores, G.A. et al. 1999. “In-Vitro Investigation of a Novel Cancer Therapeutic Method Using Embolizing Properties of Magnetorheological Fluids,” J. Magnetism and Mag. Mat., 194:167-175.

Flores, G.A. et al. 2000. “Medical Applications of Magnetorheological Fluids - A Possible New Cancer Therapy.” In: Tao, R. (ed.), Proceedings of the 7th International Conference on Electrorheological Fluids, Magnetorheological Suspensions, and Their Related Technologies, pp. 716-723, World Scientific, Singapore.

Folkman, J. September 1996. “Fighting Cancer by Attacking its Blood Supply,” Scientific American, 150.

Hecker, J.F. 1983. The Sheep as an Experimental Animal, Academic Press, London.

Kuznetsov, A.A. et al. 1997. “Ferro-Carbon Particles: Preparation and Clinical Applications.” In: Häfeli, U. et al. (eds), Scientific and Clinical Applications of Magnetic Carriers, pp. 379-390, Plenum Press, New York.

10.

Lübbe, A.S. et al. 1999. “Physiological Aspects in Magnetic Drug-Targeting,” J. Magnetism and Mag. Mat., 194:149-155.

11.

Little, R.C. 1977. Physiology of the Heart and Circulation, Year Book Medical Publication, Chicago.

12.

Liu, J. et al. 2001. “In-Vitro Investigation of Blood Embolization in Cancer Treatment Using Magnetorheological Fluids,” J. Magnetism and Mag. Mat., 225:209-217.

13.

Metz, J. 1998. “Onco Tip: A New Cancer Cure”, Univ. of Pennsylvania Cancer Center, www.oncolink.com.

14.

National Cancer Institute NCI/PDQ Patient Statement: "Melanoma" and "Breast Cancer," University of Pennsylvania Cancer Center, www.oncolink.com, February 2001, revised August 2002.

15.

Sparks, H.V. and Rooke, T.W. 1987. Essentials of Cardiovascular Physiology, University of Minnesota Press, Minneapolis.